Live webcast of event on February 27 at 8:00 a.m. ET will include participation of globally renowned gynecological oncology ...

How HRD and BRCA results steer frontline ovarian cancer maintenance—niraparib vs olaparib—plus guidance on recurrence, ...

Can artificial intelligence (AI) tools reliably handle the complexity and nuance of cancer care? A new systematic evaluation ...

Neoadjuvant chemotherapy increasingly matches upfront debulking outcomes, reducing extreme surgery risks while highlighting why patients still need access to R0 radical resection.

Breast exams, birth control and family planning are just some of the reasons not to skip your annual ob-gyn appointment.

For many patients with cancer, it is never too soon to begin discussing fertility preservation options as they begin their cancer journeys. For many patients with cancer, it is never too soon to begin ...

Hormonal and Pathophysiological Drivers: The increased cancer risk is largely driven by hyperinsulinemia suppressing sex hormone-binding globulin (SHBG), which raises circulating estrogen and ...

Yelena Zhuk, a professor in the Radiology Department of Belarusian State Medical University, told the STV television channel ...

Premenopausal women would benefit from a significantly more accurate diagnostic pathway for ovarian cancer, as a new study ...

Over the past decade, significant advances in molecular biology, genomics, immunology, and bioinformatics have reshaped our understanding of gynecologic ...